Lee demonstrated that ATR inhibition showed better synthetic lethality and increased anti-tumour immunity in cells with mismatch repair deficiency and higher infiltrating CD8+ cells in the tumour, improving prognosis in tumours exhibiting high replication stress (Wang et al., 2023). This evidence concerns the gene CD8A and neoplasm.